Kimia Biosciences share news and announcements

BSE: 530313Pharmaceuticals & BiotechnologySmall Cap

₹29.99₹0.06 (0.20%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹30.05.

52-week range of traded prices to 23 Oct 2026

₹23.20Low, 30 Mar 2026₹43.28High, 16 Feb 2026

Market cap: ₹142 Cr2,580th largest listed
P/E: 19.7
P/B: 8.0
Dividend yield: Nonein the last 12 months
ROE: 51.9%
ROCE: 19.1%
Debt to equity: 1.95
Volume, BSE: 1,361

Kimia Biosciences share news and announcements

546 announcements, routine notices left out, newest first. Page 5 of 11.

Oct 2022
- 1 Oct
  CHAIRMAN SPEECH (opens in a new tab)
Sep 2022
Aug 2022
- 29 Aug · Disclosure
  Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepa Goel (opens in a new tab)
- 26 Aug · Disclosure
  Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Deepa Goel (opens in a new tab)
- 12 Aug · Management
  Dear Sir/ Ma'am, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is informed that that Ms. Arti, Chief Financial Officer .... (opens in a new tab)
- 12 Aug · Board meeting
  Meeting of Board of Directors of the Company was held today on Friday, August 12, 2022 at 4.00 P.M IST at the Corporate Office of the Company situated at 974, 9th Floor Aggarwal Millennium .... (opens in a new tab)
- 5 Aug · Intimation Under Regulation 30 Of Drug Master File (DMF) Approval From Korea.
  Dear Sir/Madam, The Company is pleased to inform that the Company has received DMF approval of Fimasartan Potassium Trihydrate, Active Pharmaceutical Ingredients (API) from Korea. The .... (opens in a new tab)
- 4 Aug · Board meeting
  Meeting on 12 Aug 2022: quarterly results
- 4 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Dear Sir/Madam, This is .... (opens in a new tab)
Jul 2022
- 15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 4 Jul · Intimation For Transmission Of 53,18,380 Equity Shares
  Dear Sir/Madam, It is to inform you that the Company has received intimation of disclosure under Regulation 29(2) of SEBI ( Substantial Acquisition of Shares & Takeovers) Regulation, 2011 .... (opens in a new tab)
- 4 Jul · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepa Goel & PACs (opens in a new tab)
Jun 2022
- 8 Jun · Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
  39(4) & Schedule VI of the Listing Regulations, this is to inform you that the Company has sent third and final reminder .... (opens in a new tab)
- 7 Jun · Results
  This bears reference to discrepancy received on email dated 07.06.2022 in the matter of your observation that the declaration or statement of impact of Audit Qualifications has not been .... (opens in a new tab)
- 2 Jun · Discrepancy In The Certificate Issued Under Regulation 40 (9) For The Year Ended March 31, 2022.
  Dear Sir/ Madam, This bears reference to discrepancy received on email dated 01.06.2022 in the matter of your observation that the Certificate under Regulation 40(9) and filed under Regulation .... (opens in a new tab)
May 2022
- 30 May · Management
  It is informed that Mr. Sameer Goel is appointed as Chief Executive Officer of the Company in the board meeting held on May, 30, 2022 on the recommendation of Nomination and Remuneration .... (opens in a new tab)
- 30 May · Management
  It is informed that Mr. Suneel Kapur has resigned from the post of Chief Executive Officer of the Company on May 22, 2022 due to personal reasons and his resignation has been taken on record .... (opens in a new tab)
- 30 May · Board meeting
  Meeting of the Board of Directors was held on Monday, May 30, 2022 at 4:00 pm (IST), and the following businesses, amongst others, were transacted thereat: 1. The resignation .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2022: audited results
- 23 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve This is to inform that the .... (opens in a new tab)
- 17 May · Intimation Under Regulation 30 For Grant Of Certificate Of Permission To Manufacture And Marketing Of Bempedoic Acid Bulk Drug.
  Dear Sir/Madam, We are pleased to inform you that the Company has been granted permission to manufacture and marketing of Bemopedoic acid Bulk Drug under New Drug and Clincial Trials Rules, .... (opens in a new tab)
- 16 May · Board meeting
  Meeting on 16 May 2022
- 16 May · Board meeting
  Dear Sir/Madam, In compliance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 have inter-alia approved following; Appointment of Mr. .... (opens in a new tab)
Apr 2022
- 29 Apr · Submission Of Compliance Certificate Under Regulation 7(3) SEBI (Listed Obligations And Disclosure Requirements) Regulations, 2015
  In compliance with the requirements of Regulation 7(3) SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Compliance Certificate .... (opens in a new tab)
- 29 Apr · Submission Of Compliance Certificate Under Regulation 40(9) SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended March 31, 2022
  In compliance with the requirements of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Compliance .... (opens in a new tab)
- 29 Apr · Board meeting
  Appointment of Ms. Arti Dakhlani as CFO of the company, subject to approval of members at ensuing general meeting, pursuant to applicable provisions of Companies Act, 2013 read with the .... (opens in a new tab)
Mar 2022
- 29 Mar · Board meeting
  Meeting on 29 Mar 2022
- 29 Mar · Board meeting
  Appointment of Mr. Suneel Kapur as CEO of the company, subject to approval of members at ensuing general meeting, pursuant to applicable provisions of Companies Act, 2013 read with the .... (opens in a new tab)
Feb 2022
- 14 Feb · Board meeting
  We have enclosed herewith: 1. .... (opens in a new tab)
- 4 Feb · Board meeting
  Meeting on 14 Feb 2022: quarterly results
- 4 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 .... (opens in a new tab)
Jan 2022
- 29 Jan · Common And Simplified Norms For Processing Investor'S Service Request By RTA And Norms For Furnishing PAN KYC Details And Nomination.
  Important Announcement for shareholders holding shares in physical mode- As per attachment. (opens in a new tab)
- 10 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
- 7 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
Dec 2021
- 29 Dec · Recognition For Supply Of Pharmaceutical Raw Material To Bangladesh
  We are pleased to inform that the Company has been recognized/validated for supply of pharmaceutical raw material ('Bilastine') to Bangladesh by Directorate General of Drug Administration .... (opens in a new tab)
Nov 2021
- 11 Nov · Board meeting
  Board of Directors of the Company .... (opens in a new tab)
- 11 Nov · Board meeting
  Board of Directors of the Company .... (opens in a new tab)
- 2 Nov · Board meeting
  Meeting on 11 Nov 2021: quarterly results
- 2 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 .... (opens in a new tab)
Oct 2021
- 12 Oct · Shareholding for the Period Ended September 30, 2021
  Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....
- 11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
- 30 Sep · Management
  This is to inform you that Mr. Abhishek Kumar .... (opens in a new tab)
- 30 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 30 Sep · Meeting
  Kimia Biosciences Limited ('the Company') had provided remote e-voting facility to the Members to enable them to cast their vote electronically on the resolutions proposed in the Notice .... (opens in a new tab)
- 29 Sep · Meeting
  We are submitting herewith the details regarding the proceedings of the 28th AGM of the Company held on Tuesday, September 28th, 2021 at .... (opens in a new tab)
- 18 Sep · Management
  Mr. Sanjay Gupta (PAN: AFSPG4218F), has resigned from the post of Chief Financial Officer (KMP) of the Company w.e.f. close of working hours of 31st October 2021. Company is in process .... (opens in a new tab)

Kimia Biosciences share news and announcements

Oct 2022

Sep 2022

Aug 2022

Jul 2022

Jun 2022

May 2022

Apr 2022

Mar 2022

Feb 2022

Jan 2022

Dec 2021

Nov 2021

Oct 2021

Sep 2021